CV3 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER TOTAL KNEE REPLACEMENT (TKR) IN CHINA
Nov 1, 2010, 00:00
10.1016/S1098-3015(11)73076-5
https://www.valueinhealthjournal.com/article/S1098-3015(11)73076-5/fulltext
Title :
CV3 COST-EFFECTIVENESS OF RIVAROXABAN VERSUS ENOXAPARIN FOR PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) AFTER TOTAL KNEE REPLACEMENT (TKR) IN CHINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)73076-5&doi=10.1016/S1098-3015(11)73076-5
First page :
A506
Section Title :
RESEARCH PODIUM ABSTRACTS
Open access? :
No
Section Order :
1234